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Somatostatin Expression in Human Hair Follicles and
Its Potential Role in Immune Privilege
Trisia Breitkopf1, Blanche K.K. Lo1, Gigi Leung1, Eddy Wang1, Mei Yu1, Nicholas Carr2, David Zloty3,
Bryce Cowan3, Jerry Shapiro3 and Kevin J. McElwee1
Immune privilege (IP) is believed to exist in the anagen hair follicle (HF). Studies have shown that downregulation
of major histocompatibility complex Class I occurs and immunosuppressive factors are expressed in the HF bulb
and bulge. However, demonstration and quantification of functional IP in HF cells are required. We examined the
middle (sheath) and lower (bulb) portions of the human HF using quantitative real-time RT-PCR (qPCR),
immunohistology, ELISA, in vitro coculture with peripheral blood mononuclear cells (PBMCs), and flow
cytometry. We found that HF cells, relative to non-follicular epidermal cells, failed to promote allogeneic PBMC
proliferation and CD4þ and CD8þ IFNg production. By qPCR, we found significant downregulation of Class I and
Class II HLA alleles in both the bulb and sheath, and upregulation of multiple immunoregulatory genes. It is
noteworthy that somatostatin (SST) was significantly upregulated relative to epidermis. By immunohistochem-
istry, SST was most strongly expressed in the HF outer root sheath, and, by ELISA, cultured sheath cells secreted
SST. PBMCs, cultured with stimulatory allogeneic epidermal cells and SST, secreted significantly less IFNg than
controls. Addition of SST antagonists to PBMCs cocultured with allogeneic HF cells increased IFNg secretion. The
data identify SST as a secretory factor potentially contributing to the HF IP repertoire.
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INTRODUCTION
The tissue-protective phenomenon of immune privilege (IP) is
believed to exist in the anagen-stage hair follicle (HF) (Paus
et al., 2005). First recognition that HFs may exhibit IP was
indicated by the studies involving allografts of pigmented skin
onto albino skin beds in guinea pigs, in which black hair
survived and grew, implying protection of grafted melanocytes
by host HF bulbs (Billingham and Silvers, 1971). More recently,
scalp HF dermal sheath tissue from a male human was
successfully grafted to the arm of a female human (Reynolds
et al., 1999). These studies suggest that HFs retain functional IP.
The nature of HF IP has been investigated largely using
immunohistological studies. The lower transient cycling
portion of anagen-stage HFs exhibit decreased major
histocompatibility complex (MHC) Class I expression and
low numbers of perifollicular macrophages and T cells during
anagen (Westgate et al., 1991; Christoph et al., 2000).
Immunosuppressants are secreted from lower HFs, for
example, adrenocorticotropin (Slominski et al., 1998),
macrophage migration inhibitory factor (MIF) (Meyer et al.,
2008), and a-melanocyte stimulating hormone (aMSH)
(Botchkarev et al., 1999). HFs may also regulate lymphocyte
activity through Fas–Fas ligand as identified in eye graft
models (Boffa et al., 1995; Freyschmidt-Paul et al., 2003;
Ferguson and Griffith, 2006).
Studies suggest that the HF bulge area and its stem cell
reservoir also exhibit IP. By immunohistology, expression of
several immunosuppressant factors, such as aMSH, transform-
ing growth factorb2 (TGFb2), MIF, and indoleamine 2,3-
dioxygenase, have been observed in and around the HF bulge
(Meyer et al., 2008). For cell-surface markers, MHC Class I, II,
and b-2-microglobulin are decreased, but CD200 is increased
in the bulge and adjacent outer root sheath (ORS) relative to
non-follicular epithelium (Rosenblum et al., 2004; Ohyama
et al., 2006; Meyer et al., 2008). As such, more than one
group of HF cells may exhibit IP, although with different
characteristics.
It has been hypothesized that breakdown of HF IP may lead
to the development of diseases such as alopecia areata and
scarring alopecias (Paus et al., 1993; Christoph et al., 2000;
Paus et al., 2003). In alopecia areata–affected HFs, MHC Class
I and II expression increases (Brocker et al., 1987; Zhang and
Oliver, 1994; McElwee et al., 2002). In recent research, an
apparent deficiency in Red/IK, an immunoregulatory cytokine,
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was associated with alopecia areata development in advance
of hair loss (Kang et al., 2011).
To date, there have been few quantitative or functional
studies to demonstrate that HFs exhibit functional IP. Our aim
was to evaluate IP in different portions of healthy human
primary anagen HFs, comparing characteristics with normal
epidermis as a control. We determined IP-related gene
expression in HFs by quantitative real-time RT-PCR (qPCR).
The discovery of somatostatin (SST) in HFs led us to cell
culture experiments, examining HF cell and SST effects on
healthy histoincompatible peripheral blood mononuclear cells
(PBMCs). Our research suggests that IP in HFs is mediated
partly by SST.
RESULTS
HF cell effect on allogeneic PBMCs
We examined the functional IP capabilities of healthy human
HFs in vitro. Primary cells from the cycling lower third of the
HFs (bulb), the middle third (sheath), or non-follicular epider-
mal tissues as a control were cocultured with histoincompa-
tible PBMCs, similar to a mixed lymphocyte reaction
(Wojtusciszyn et al., 2009; Bocian et al., 2010; Inayat et al.,
2010). By detecting IFNg secretion, we wanted to see whether
HF cells attenuated PBMC stimulation. After 5 days, ELISA
supernatant analysis revealed that HF bulb and sheath cells
elicited significantly less IFNg secretion from PBMCs than
those cultured with epidermal cells (Figure 1a). IFNg detected
in PBMC/epidermal supernatant averaged 35.3 pg ml 1,
whereas PBMC/bulb supernatant averaged 18.4 pg ml1
(P¼ 0.03) and PBMC/sheath averaged 9.8 pg ml 1 (P¼0.007).
A flow cytometry analysis of IFNg expression in cell
populations on day 5 consistently showed that there were
reduced percentages of CD4þ IFNgþ and CD8þ IFNgþ
PBMCs in cultures with HF bulb and sheath cells relative to
PBMCs cocultured with epidermal cells (Figure 1b and c).
When the PBMC/HF percentages were divided by the percen-
tages for PBMC/epidermal cells, there was a significant
difference in relative expression between the groups
(Figure 1b). Similarly, HF cells did not induce as much T-cell
proliferation as epidermal cells with values for CD4þKi-67þ
and CD8þKi-67þ cells significantly reduced (Figure 1b and c).
IP-related gene expression in HFs
We evaluated mRNA expression levels in 42 IP-related genes
in HF bulbs and sheaths relative to non-follicular epidermis by
qPCR (Supplementary Table S1 online; Figure 2). As expected,
we found multiple class I HLAs A, B, C, and Class II genes DP,
DR, and DQ, significantly downregulated in HF bulbs and
sheaths compared with the epidermis (Figure 2b). Transporter
associated with antigen processing 1 (TAP1) was significantly
downregulated in HFs. b-2-Microglobulin and MHC Class I
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Figure 1. Human peripheral blood mononuclear cells (PBMCs) are
significantly less stimulated by allogeneic hair follicle bulb and sheath cells
relative to epidermal cells. Non-follicular epidermal cells or hair follicle (HF)
cells (2 104) were cocultured with allogeneic PBMCs (2 105) for 5 days.
(a) The mean pg ml 1 IFNg detected in supernatant was significantly less in
PBMC/HF cultures than in PBMC/epidermal cultures. By flow cytometry,
CD4þ and CD8þ PBMCs cultured with HF cells showed significantly less
coexpression of (b) IFNg and (c) Ki-67 relative to PBMCs cultured with
epidermal cells. (c) Dot plots show percentage of double-positive cells out of
total CD4þ or CD8þ cells; representative of three separate experiments. Bar
graphs show the mean of three different experiments±SEM, with the Student’s
t-test showing significance, *Po0.05.
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chain–related genes A (MICA) and B (MICB) were significantly
downregulated in the HFs. HLAG, a non-classical immuno-
regulatory Class I, was significantly upregulated. For secretory
factors, most notably, somatostatin (SST) was significantly
upregulated in the HF sheath 5.9-fold and the bulb 94.2-fold
(Figure 2c). TGFb2, aMSH, MIF, and calcitonin gene–related
peptide (CGRP) were significantly upregulated in the sheath
(8-, 4.3-, 2.5-, and 5-fold, respectively).
SST production in HFs
Immunohistology revealed strong SST expression in the HF
(Figure 3b), particularly in the ORS. There was an internal cell
layer with stronger label intensity in the outer ORS just under
the arrector pili muscle, close to the putative bulge area
(Figure 3d). In cell culture experiments, human HF sheath,
bulb, and interfollicular epidermal cells were cultured indivi-
dually for 5 days. More SST was detected in sheath cell culture
supernatants by ELISA in three separate experiments. On
average, SST was significantly higher in quantity on each
day examined in HF sheath supernatants relative to epidermal
cell culture supernatants (Figure 3f).
Exogenous SST effect on PBMCs stimulated by allogeneic
epidermal cells
The goal of this study was to determine whether SST is capable
of suppressing stimulation of immune cells. Production of IFNg
after CD3/CD28 microbead stimulation of PBMCs could not
be abrogated with SST (not shown). We used allogeneic non-
follicular epidermal cells, which do not exhibit IP, to stimulate
the PBMCs. We then added SST to the cultures to see whether
there was an effect on IFNg production. SST significantly
inhibited IFNg secretion from PBMCs stimulated with allo-
geneic epidermal cells in four of five concentrations tested
(Figure 4). The lower, physiological concentrations of SST
appeared to inhibit IFNg secretion more than the higher
concentrations. The 16 pg ml1 SST concentration significantly
inhibited IFNg secretion by B60% and 50 pg ml 1 by 65%.
Antagonizing SST in allogeneic HF sheath/PBMC culture
The purpose of this study was to ascertain how much of a role
SST has in overall HF sheath IP. We wanted to see whether
blocking SST enabled PBMCs to respond to the allogeneic
cells. We used two different methods to block SST expression.
First, we used cyclosomatostatin (cSST), an SST receptor
antagonist that has been shown to counteract the inhibitory
effect of SST (Fries et al., 1982; Luo et al., 2010). Our results in
culturing sheath cells with allogeneic PBMCs showed that
wells with 50 pg ml1 of cSST contained significantly more
IFNg than wells without cSST (Figure 5a). The second method
used SST receptor 1 (SSTR1) recombinant protein to bind
SST secreted from sheath cell culture. With three different
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Figure 2. Quantitative PCR mRNA expression of immune privilege–related
genes. Hair follicle sheath (n¼5) and bulb (n¼ 5) gene expression were
examined relative to non-follicular epidermis (n¼ 10). Genes are grouped as
(a) cell-surface markers, (b) histocompatibility-associated antigens, (c) and
secretory factors. Values were obtained using the 2 DDCT fold-change method.
For SE, the SD of relevant samples was divided by the square root of the
number of samples. The calculation for error bars was 2DDCTþ SE minus fold
change or fold change minus 2DDCT–SE to find the range of difference.
Statistical significance was determined by the Student’s t-test, *Po0.05.
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concentrations of SSTR1, there was an increased IFNg secre-
tion from PBMCs relative to the control, of which one
concentration achieved significance (Figure 5b).
DISCUSSION
Here, we show HF sheath and bulb cells from one person
have a suppressive effect on immune cells from a genetically
different individual. By ELISA, we found that HF cells in a
5-day culture did not stimulate IFNg secretion from PBMCs, as
much as non-follicular cells. Theoretically, only a small
percentage of the CD4þ or CD8þ PBMCs would be respon-
sive to the allogeneic cells exhibiting foreign HLA. Conse-
quently, the secreted IFNg detected in the control populations
was less than that observed in cells polyclonally activated by
CD3/CD28. Our subsequent flow cytometry studies recon-
firmed our IFNg ELISA results; subsets of CD4þ and CD8þ
PBMCs produced IFNg in response to allogeneic epidermal
cell challenge. Similarly, subsets of CD4þ and CD8þ PBMCs
expressed cell-proliferation marker Ki-67. However, there
was a significant decrease in IFNg production in both CD4þ
and CD8þ PBMCs cultured with HF cells, especially sheath,
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Figure 3. Somatostatin detection in hair follicles. Relative to (a) negative
control, strong somatostatin (SST) expression was detected in (b) hair follicle
(HF) outer root sheath (ORS). (c) Positive control human pancreas exhibited
SST expression in islets. (d) The outer cell layer of the ORS near the bulge
region was labeled more intensely; (e) expression was lower in the bulb.
Bar¼200mm (a, b) and 100mm (c, d, and e). HF bulb, sheath, and non-
follicular epidermal cells were cultured (2104 per well). Supernatant was
extracted on days 1, 3, and 5, and SST detected by ELISA. (f) Sheath cells
secreted significantly higher SST than epidermal cells. Values of three different
experiments were averaged (±SEM) and significance determined by the
Student’s t-test, *Po0.05.
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Figure 4. Exogenous somatostatin has an inhibitory effect on allogeneically
stimulated peripheral blood mononuclear cells (PBMCs). Human PBMCs
(2 105) were cocultured with stimulating allogeneic epidermal cells (2104)
and several concentrations of somatostatin (SST), as shown on the x axis. Each
well contained PBMCs, epidermal cells, and SST, except for controls. After 5
days, supernatant was collected and IFNg was detected by ELISA. In each
experiment, the IFNg pg ml1 values of the wells with SST were divided by the
PBMC/epidermal well without SST, to give a percentage difference. The
relative percentages from three different experiments were averaged (±SEM)
and significance was determined by the Student’s t-test, *Po0.05.
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relative to epidermal cells. Further, there was a significant
reduction in Ki-67 expression in CD4þ and CD8þ PBMCs
cocultured with HF cells. These results give further functional
evidence to support the existence of IP in HFs.
Differential expression of immunoregulatory factors in HFs
Our finding of significant downregulation of HLA Class I A, B,
and C mRNA in the HFs compared with that in the epidermis
was consistent with previous studies (Harrist et al., 1983;
Meyer et al., 2008). It follows that b-2-microglobulin, a
component of HLA Class I, was also significantly
downregulated. Subsets of HLA Class II genes, DR, DQ, and
DP a1 and b1 chains were also significantly downregulated in
the HFs. Finding significant downregulation of TAP1, involved
in transporting antigens for presentation, further supports the
absence of HLA Class I. MICA and MICB are associated with
cell stress responses and tumor growth (Groh et al., 1996).
They are ligands for NKG2D, which activates natural killer
cells and certain T-cell subsets (Holmes et al., 2002) if MHC
Class I is absent on cells (Biassoni et al., 2001). Our finding
that MICA and MICB mRNA was downregulated in normal
HFs is consistent with previous observations of MICA by
immunohistology (Ito et al., 2008). CD200 is expressed in the
bulge of human HFs and the companion layer (Ohyama et al.,
2006; Meyer et al., 2008). The apparent (although not
statistically significant) downregulation of CD200 here may
seem contradictory. However, as mRNA expression is
presented as an average for all sheath cells, the value will
not accurately reflect expression limited to the bulge region.
Of secretory factors, TGFb2, aMSH, and MIF mRNAs were
all significantly upregulated in the sheath consistent with
previous observations (Meyer et al., 2008). TGFb1 and
TGFb2 can convert effector T cells into regulatory T cells,
which suppress the immune response (Bellinghausen et al.,
2006). aMSH suppresses the activities of IL-1, tumor necrosis
factora, and blocks endotoxin via toll-like receptor-4 (Lipton
and Catania, 1997). MIF has a role in preventing natural killer
cell attack (Apte et al., 1998). CGRP was significantly
upregulated in the sheath. As a neuropeptide found in eye
aqueous humor, an IP site, it has been observed to suppress
nitric oxide production by macrophages and protect
allogeneic tissue transplants (Taylor et al., 1998; Zhang
et al., 2009). We found that HLAG mRNA was significantly
upregulated in the human HF; a previous study showed
protein expression in mouse HFs (Paus et al., 1994). This
non-classical Class I gene has been implicated in IP at the
human materno–fetal interface (Kovats et al., 1990; Hunt
et al., 2006; Rizzo et al., 2011) and in Rhesus monkey
placenta and testis (Ryan et al., 2002). HLA-G inhibits
effector T cells (Carosella et al., 2001) and natural killer
cells (Rouas-Freiss et al., 1997; Rajagopalan and Long, 1999;
Le Bouteiller, 2000), and it is highly expressed in human
melanoma (Paul et al., 1998).
SST is significantly expressed in HFs
From the examination of IP-related gene expression, most
notable was our finding of significantly upregulated SST
mRNA in the HF. It is a regulatory neuropeptide secreted in
the intestine and pancreas (Corleto, 2010), the central nervous
system (Lamberts et al., 1996), and the hypothalamus (Hisano
and Daikoku, 1991), and it has also been detected in rabbit
eye aqueous humor (Taylor and Yee, 2003). SST has different
functions in different tissues and can have a role in immune
regulation (Florio and Schettini, 2001). SST inhibits chemotaxis
by Substance P–activated neutrophils (Kolasinski et al., 1992).
Lymphocytes are known to express the receptors SSTR2 (Elliott
et al., 1999), SSTR3, and SSTR5 (Oomen et al., 2000). SST was
shown to decrease IFNg secretion from stimulated human
PBMCs (Muscettola and Grasso, 1990) and inhibits
proliferation of alloantigen-stimulated T cells (Casnici et al.,
1997). One study showed that SST did not suppress
IFNg secretion by PBMCs non-specifically stimulated with
lipopolysaccharide (ter Veld et al., 2009), which is consistent
with our results using non-specific CD3/CD28 stimulation.
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Figure 5. Antagonizing somatostatin in peripheral blood mononuclear cell
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We detected a significant production of SST peptide in the
ORS layers along the length of the HF by IHC, as well as in
sheath cell culture supernatant by ELISA. By IHC, we showed
that some cells in the putative bulge area of the HF stained
more intensely for SST. Surprisingly, the bulb seemed to
produce cumulatively less SST in cell culture compared with
the sheath section. Potentially, microRNA activity may cause
posttranscriptional suppression of the mRNA (Bartel, 2009),
affecting production of the SST peptide in the bulb. As SST
may inhibit cell proliferation (Liebow et al., 1989; Fais et al.,
1991), it is logical that it is not produced in the bulb, as that is
an area of cell growth in the HF. Normal HFs express SSTR 1
and 2, whereas epidermis, sebaceous glands, and sweat
glands most strongly express SSTR 1-3 (Hagstromer et al.,
2006), suggesting SST may have other non-immunoregulatory
roles in HFs.
Potential role of SST in HF IP
In vitro, we showed that SST suppressed IFNg secretion from
PBMCs cultured with stimulating allogeneic epidermal cells.
Lower concentrations of SST yielded stronger inhibition than
higher concentrations. This result may be due to desensitiza-
tion of G protein–coupled SSTRs with excessive, prolonged
exposure (Bohm et al., 1997; Kelly et al., 2008). In other
studies, SST effects on immune cells depended on the
underlying cell system (ter Veld et al., 2009). SST induced
IL2 secretion by unstimulated autoimmune-related antigen-
specific Th1 mouse cells, but it induced IL4 secretion from
antigen-stimulated cells (Levite, 1998). With Th2 cells, SST
stimulated IFNg release—an unusual event for Th2 cells. It
appears that in different scenarios, SST can either stimulate or
suppress T-cell activity. Levite argues that the effects of SST are
largely dependant on the context, whether the T cells are
activated, what cell type, SST concentration, and what other
cytokines are in the vicinity (Levite, 2008).
We showed that antagonizing SST activity in vitro, by
blockade of SST receptors using cSST, or binding free SST
with a recombinant SST receptor, was associated with
increased IFNg production by PBMCs in response to allo-
geneic HF sheath cells. The results suggest that SST secreted
from HF sheath cells supports immunoregulation and con-
tributes to IP. SST may be one of several components of HF
sheath cell IP, but interfering with its IP function was not fully
compensated by other HF-derived IP factors.
The results presented here contribute quantitative gene
expression data on IP in HFs. We also show that the normal
HF can inhibit allogeneic PBMC stimulation, and that it
expresses SST, especially sheath cells. Blocking SST in
PBMC/sheath coculture partially reduced the IP properties of
HF sheath cells. We propose that SST is a potential contributor
to IP in HF sheaths.
MATERIALS AND METHODS
Tissues
Tissues were obtained from subjects undergoing cosmetic surgery
with approval by the University Clinical Research Ethics Board. The
Declaration of Helsinki Principles was followed; consent was not
required as tissues obtained from surgical procedures are considered
discarded under Canadian law. In total, 27 healthy tissues containing
HFs came from 18 female individuals and 9 male individuals (mean
age 53.4±10.8 years), and 20 normal epidermal tissues came from
14 female individuals and 6 male individuals (mean age 57.9±13.9
years). Live HFs were isolated by cutting off the epidermis and
plucking the entire follicle including the collagen capsule. For tissues
frozen in RNA stabilizer (RNAlater, Qiagen, Mississauga, ON), HFs
were individually dissected. For each follicle, dermis and fat were
removed, as well as the HF infundibulum and epidermis. The HFs
were cut to isolate the lower one third including the ‘‘bulb’’ region,
from the root sheaths and hair fiber ‘‘sheath’’ portion. The non-
follicular epidermis was isolated as a control, cutting off as much
dermis as possible.
Processing live tissue into single-cell suspensions
Tissues were washed in Dulbecco’s phosphate-buffered saline (Invi-
trogen, Burlington, ON) with 1% antibiotic-antimycotic (Invitrogen).
Specimens were placed in 25.0 caseinolytic units per ml dispase
(Invitrogen) with 1% antibiotic-antimycotic at 4 1C. The following
day, tissues were incubated in TrypLE Select (Invitrogen), processed
through 70-mm cell strainers, washed by centrifugation in Dulbecco’s
phosphate-buffered saline containing antibiotics, and resuspended.
An equal amount of medium was added and the cells were
centrifuged at 300 g. Viability and cell count was determined using
Trypan blue dye exclusion and a hemocytometer.
Isolation of PBMCs
Peripheral blood from healthy volunteers, 3 female volunteers and
5 male volunteers (mean age 28.3±3.6 years), who gave informed
consent was collected in heparinized Vacutainers (VWR, Edmonton,
AB). PBMCs were isolated with Ficoll-paque density-gradient cen-
trifugation (GE Life Science, Baie d’Urfe, QC). Cells were washed in
R10 consisting of 1640 RPMI culture medium, 10% heat-inactivated
fetal bovine serum, 2 mM L-glutamine, 50mg ml 1 streptomycin, and
50 U ml 1 penicillin (Invitrogen). PBMCs were counted using Trypan
blue and cryopreserved in a base medium with 20% fetal bovine
serum and 10% DMSO at 1 106 cells per ml in liquid nitrogen.
ELISA
Human IFNg was determined using a Quantikine ELISA kit (R&D
Systems, Burlington, ON). Wells were duplicated and read on a
microplate reader at 450 nm with a correction wavelength of 540 nm.
SST was determined by competitive ELISA (USCN Life Sciences,
Wuhan, China). Duplicate wells were read at 450 nm. Optical density
readings were plotted against standard concentrations according to
the manufacturers’ instructions.
PBMC coculture with allogeneic HFs or epidermal cells
Between 65 and 90 HFs were processed from tissue (n¼ 4) to obtain a
sufficient number of cells for each assay. R10 was chosen as the
coculture medium because it was optimal for PBMC survival (data not
shown). Wells contained either PBMCs only (n¼ 3), PBMCs and
epidermal cells, PBMCs with HF bulb cells, or PBMCs with HF sheath
cells. PBMCs were seeded at 2 105 cells per well onto 96-well
U-bottom culture plates (Sarstedt, Montreal, QC), and then tissue cells
were seeded at 2 104 cells per well with a per-well total volume of
300ml. Cells were cocultured for 5 days; the supernatant was
collected and stored at  80 1C until IFNg ELISA analysis.
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Flow cytometry
PBMCs (n¼ 3) were cultured with HF or epidermal cells (n¼ 3), using
the same methods shown in the previous section. PBMCs were
labeled for CD4 (OKT-4), CD8a (RPA-T8), Ki-67 (20Raj1), and IFNg
(4S.B3); CD14 (61D3) was used to gate out monocytes from the
analyses (all eBioscience, San Diego, CA). Brefeldin A (1mg ml 1)
was added to the culture 4 hours before cell collection (eBioscience).
We followed standard protocols using a Staining Buffer Set and
isotype controls (eBioscience). Samples were analyzed on a FACS-
Canto II flow cytometer using FACS Diva software (BD Biosciences,
Mississauga, ON).
RNA isolation and cDNA synthesis
Samples containing HFs (n¼ 12) or epidermis (n¼ 15) were micro-
dissected into bulb and sheath portions, placed in RLT lysis buffer
(Qiagen), and disrupted by sonication or with a mortar and pestle.
Samples were then homogenized in QIAshredder tubes (Qiagen).
Total RNA extraction was carried out using the RNeasy Fibrous Tissue
Mini Kit (Qiagen) including an RNase-Free DNase set. For comple-
mentary DNA synthesis, we used the Superscript III Reverse Tran-
scriptase system (Invitrogen). Each reaction included 0.5mg RNA and
150 ng random primers according to the manufacturer’s protocol.
RNaseH was used to remove complementary RNA. The thermal
cycler used was the Mastercycler Gradient (Eppendorf, Mississauga,
ON) and cDNA was stored at  20 1C.
Quantitative RT-PCR
qPCR triplicate quality check for the cDNA was performed using 18S
primers (Ambion, Streetsville, ON). We used an MJ Research DNA
Engine Opticon real-time cycler (Bio-Rad Laboratories, Mississauga,
ON). For qPCR studies, we diluted the cDNA to 1 ngml 1 and used
the DyNAmo HS SYBR Green qPCR kit (Finnzymes, Espoo, Finland).
Reactions were duplicated and 18S was the internal control. Gene
sequences of interest were obtained from FASTA, and primer
sequences (Invitrogen) were designed using Primer3 online software
at http://frodo.wi.mit.edu/primer3/ (Rozen and Skaletsky, 2000), as
well as Primer Blast at http://www.ncbi.nlm.nih.gov/tools/primer-
blast/. Sequences were checked for specificity with BLAST online
database from NCBI at http://blast.ncbi.nlm.nih.gov/Blast.cgi. Primers
(Supplementary Table S2 online) were tested to confirm specificity by
examining melting curves for purity.
qPCR statistical analysis
We used the 2 DDCT fold-change method to determine relative
mRNA expression. For SE, the SD of samples was divided by the
square root of the number of samples. For error bars, we used
2DDCTþ SE minus fold change or fold change minus 2DDCT–SE to
find the range of difference. Statistical significance was calculated
using the Student’s t-test with Po0.05 indicating significance.
Immunohistochemistry
Tissues containing HFs (n¼ 4) were formalin fixed, embedded in
paraffin, and cut into 5–6mm-thick sections. Slides were deparaffi-
nized and hydrated. The Dako LSABþ System-HRP kit (K0679;
Mississauga, ON) was used. A peroxidase block and then protein
block were applied. Thereafter, either negative control diluent or
primary polyclonal, rabbit anti-human SST antibody (AHP53; Serotec,
Kidlington, UK) was applied. After overnight incubation, slides were
incubated with kit biotinylated linker then streptavidin peroxidase.
Chromagen substrate 3,30diaminobenzidine was used to detect anti-
body with hematoxylin counterstain.
Cell culture to detect SST
HF tissues (n¼ 4) were microdissected and 50–65 anagen HF bulbs
and sheaths were isolated per sample, as well as non-follicular
epidermis as a control. HF bulb and sheath, as well as non-follicular
epidermal cells, were individually resuspended in a Defined Kerati-
nocyte Serum-Free medium (Invitrogen) and seeded at 2 104 cells
per ml per well on a 24-well Collagen I plate (BD Biosciences) and
cultured for 5 days. Supernatant from the same well was withdrawn
on days 1, 3, and 5 and stored at  80 1C until ELISA analysis.
Differences in pg ml 1 from day 1 to day 3, or day 3 to day 5, were
calculated and results were adjusted to account for the total culture
media quantity remaining in each well at each time point.
PBMC culture with stimulants and SST
In the first method, epidermal tissues (n¼ 3) were processed into
single-cell suspensions in R10. Wells of a 96-well U-bottom plate
(Sarstedt), except for controls, contained PBMCs (2 105), allogeneic
epidermal cells (2 104), and 16, 160, 50, 500, or 1000 pg ml 1 of
SST (S0885, Sigma, Oakville, ON). Cells were cocultured for 5 days;
supernatant was collected and stored at  80 1C until IFNg ELISA
analysis. In the second method, PBMCs (n¼ 3) were resuspended in
R10 medium at 1 105 cells per 100ml. CD3/CD28 Dynabeads
(Invitrogen) were added at a ratio of four PBMCs to one bead to
obtain half-maximal stimulation (data not shown). Wells contained
unstimulated PBMCs, PBMCs with Dynabeads only, and PBMCs with
Dynabeads and SST. After 18 hours culture, supernatant was
collected.
Antagonizing SST in cell culture
Two different methods were used in order to block SST in HF
sheath cell culture. SST receptors were blockaded using cSST (C4801,
Sigma), and SSTR1 recombinant protein (Abnova, Taipei, Taiwan)
was used to bind SST. PBMCs (2 105) (n¼ 4), cSST (25 or
50 pg ml 1), and primary allogeneic HF sheath cells (2 104)
(n¼ 3), each suspended in R10, were added to a 96-well U-bottom
plate. The negative control had PBMCs only and the positive
control contained PBMCs and HF sheath cells only. Cells
were cocultured for 5 days; supernatant was collected and stored
at  80 1C until IFNg ELISA analysis. The second method was
identical to the first except that SSTR1 (50, 250, or 500 pg ml 1)
was substituted for cSST (PBMCs n¼ 4, HFs n¼ 2). In preliminary
studies, both antagonists individually cultured with PBMCs (n¼ 3 per
group) alone did not yield significantly different IFNg expression
(not shown).
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